Cryoport (CYRX) Prelim. Q2 Results Miss Consensus
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/18/2026
- Wall St ends lower for the day and week as chip selloff broadens
- Netflix earnings forecast disappoints Wall Street, shares tumble
- HSBC upgrades Apple to Buy, sees "strong cycle ahead"
- Kimi K3 AI breakthrough: What Wall Street analysts say about China’s OpenAI threat
- Why the Fed may still need to hike rates
- Assassin's Creed Black Flag Resynced sells 3M copies in a week
- Magnitude 7.4 earthquake strikes coast of Chiapas, Mexico; Tsunami waves are possible
- Magnitude 7.4 earthquake strikes Puerto Madero, Mexico, USGS says
- Adobe has received a takeover approach by a Big Tech company - Betaville
- Wall St ends lower for the day and week as chip selloff broadens
Cryoport Announces Certain Preliminary Results for Second Quarter & Updates 2023 Revenue Expectations
July 12, 2023 4:05 PM EDTSecond quarter results were impacted by weaker than expected global demand for capital equipment; clinical trial start delays; and slower than expected ramps from certain clientsSecond quarter revenue expected in the range of $56.5 - $57.5 millionFull year 2023 revenue now expected in the range of $233 - $243 millionLong-term outlook robust with cell and gene therapy industry expected to grow at a ten-year CAGR in excess of 22%
NASHVILLE,... More
